APA (7th ed.) Citation

Y, H., & T, I. (2013). The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab. Clinical rheumatology, 32(1), 123. https://doi.org/10.1007/s10067-012-2103-4

Chicago Style (17th ed.) Citation

Y, Hirabayashi, and Ishii T. "The DAS28-ESR Cutoff Value Necessary to Achieve Remission Under the New Boolean-based Remission Criteria in Patients Receiving Tocilizumab." Clinical Rheumatology 32, no. 1 (2013): 123. https://doi.org/10.1007/s10067-012-2103-4.

MLA (9th ed.) Citation

Y, Hirabayashi, and Ishii T. "The DAS28-ESR Cutoff Value Necessary to Achieve Remission Under the New Boolean-based Remission Criteria in Patients Receiving Tocilizumab." Clinical Rheumatology, vol. 32, no. 1, 2013, p. 123, https://doi.org/10.1007/s10067-012-2103-4.